DXN's investor relations keep shareholders informed about the company's progress and plans
Cyberjaya, 29 October 2025 – DXN Holdings Bhd. (“DXN” or the “Company”) [德信控股], a leading global manufacturer of nutraceutical products, today announced its unaudited results for the second quarter ended 31 August 2025 (“2QFY26”) and first half unaudited financial results for the financial year ending 28 February 2026 (“1HFY26”) for the Company and its subsidiaries.
For 2QFY26, DXN recorded a net profit of RM70.3 million, up 6.5% year-on-year (“YoY”) from RM66.0 million in 2QFY25. Earnings before interest, tax, depreciation and amortisation (“EBITDA”) increased 8.4% YoY to RM136.0 million (2QFY25: RM125.4 million), lifting the EBITDA margin to 28.3% (2QFY25: 25.7%).
Quarterly revenue stood at RM481.2 million versus RM488.4 million in 2QFY25, reflecting temporary foreign exchange translation effects and higher member stock levels in Morocco. Excluding these factors, sales would have been higher in key markets as revenue in local currencies remained positive with Peru, Bolivia, Mexico and India posting growth rates ranging from 2.0% to 38.0%.
Reaffirming its commitment to shareholder value, the Board declared a second interim dividend of 0.8 sen per share, bringing total dividends for 1HFY26 to 1.7 sen per share (total payout of RM84.5 million), representing a payout ratio of 58.6%.
Executive Chairman and Founder of DXN, Datuk Lim Siow Jin (拿督林孝仁) shared, “Our strong business fundamentals and healthy global demand continue to support steady growth despite ongoing macroeconomic challenges. We remain proactive in managing foreign exchange volatility, inflationary pressures, and geopolitical uncertainties as we pursue our long-term expansion strategy.”
“We are accelerating the diversification of our product portfolio with a focus on functional wellness and expanding our global footprint. Key developments include new facilities in Peru, Bolivia, Brazil, and Kelantan, Malaysia. In Brazil, we are establishing a vertically integrated ecosystem, from coffee plantation and processing in Ibia to distribution via our São Paulo hub. This expansion underscores our strategy to build sustainable, regionally integrated operations supported by innovation and scalability,” he concluded.
For 1HFY26, DXN posted revenue of RM960.3 million (1HFY25: RM963.5 million), reflecting currency translation headwinds offset by solid sales growth across Latin America, India, Turkey, and Mongolia. Revenue in local currency terms remain strong, with growth ranging from 2.0% to 44.0% across Peru, Bolivia, Mexico, India, Turkey, and Mongolia. Additionally, EBITDA was RM275.5 million (1HFY25: RM277.3 million), while net profit came in at RM144.2 million (1HFY25: RM151.5 million).
The Group remains financially strong, with cash and cash equivalents of RM617.5 million as at 31 August 2025, comfortably exceeding total borrowings of RM178.1 million. Net operating cash flow for the quarter stood at RM121.5 million, reflecting prudent working capital management and healthy business fundamentals.
Health
Food and Beverage
Personal Care
Nutrition
Beauty
Branch
Business
Register